AMUNIX, INC.

Company Information

Company Name
AMUNIX, INC.
Address
500 Ellis Street, Suite B
MOUNTAIN VIEW, CA, 94043-
Phone
n/a
URL
n/a
DUNS
621413512
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$366,097.00
3
SBIR Phase II
$2,006,049.00
2
Chart code to be here

Award List

  1. Drug binding microprotein domains for targeted delivery of cytotoxic drugs

    Amount: $108,284.00

    DESCRIPTION (provided by applicant): Targeted delivery of cytotoxic drugs to tumor tissues is an effective strategy to minimize drug exposure of normal tissues and thus improve the toxicity and effica ...

    SBIR Phase I 2007 Department of Health and Human Services
  2. Glycine rich sequences with pharmacokinetic enhancing properties of PEG polymers

    Amount: $100,263.00

    DESCRIPTION (provided by applicant): Protein drugs have been approved for many therapeutic indications and represent a rapidly growing segment of the pharmaceutical industry. However, many approved pr ...

    SBIR Phase I 2007 Department of Health and Human Services
  3. Targeting toxins to tumors using microproteins

    Amount: $995,124.00

    DESCRIPTION (provided by applicant): Treatment of metastatic tumors is a major health challenge. Recently, antibody-based therapies have been developed that are more specific and have fewer side effec ...

    SBIR Phase II 2008 Department of Health and Human Services
  4. Glycine rich sequences with pharmacokinetic enhancing properties of PEG polymers

    Amount: $1,010,925.00

    DESCRIPTION (provided by applicant): The market for protein-based biopharmaceuticals is rapidly expanding. However, the clinical utility of many proteins is limited by their short serum half-life, req ...

    SBIR Phase II 2008 Department of Health and Human Services
  5. XTENylation of enfuvirtide to generate a bio-better product with improved dosing

    Amount: $157,550.00

    DESCRIPTION (provided by applicant): Enfuvirtide (Fuzeon, T-20) is a peptide HIV entry inhibitor currently dosed twice daily by subcutaneous injection. While proven to be efficacious and safe, enfuvir ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government